IL-22 has also been shown to be protective in colitis [19,20], including the DSS-induced colitis model using IL-22 or the stabilized IL-22Fc fusion protein UTTR1147A used in the experiments described here, and is under clinical development in IBD [21]. This evidence concerns the gene IL22 and colitis.